Community Fundraising January Wrap-Up
7 February 2020
The first month of the year is over already and the time has come again to recognise the incredible work of our community fundraisers. Throughout January our community created, hosted and participated in some amazing events, each of them helping us on our quest to reach zero deaths from melanoma.
You might remember Jenny Keck and her Bayview Country Picnic from our #fundraiserfriday late last year. Just before Christmas in 2018, Jenny’s daughter-in-law Amanda was diagnosed with melanoma. Jenny hosts a backyard music festival every January to raise money for a worthy cause and this year, the backyard music festival raised $1411 for MIA! Big thanks to Jenny, Amanda and MIA's Speakers Hub speaker Kristy Roberts for helping make the day a huge success.
The staff at Bub’s Famous Fish & Chips in Nelson Bay wore specially designed Game On Mole shirts throughout the month of January to promote melanoma awareness and their fundraising initiative where $1 from every fish and chips sold was donated to MIA. A big shout out to Joanne Howarth and her team at Bub's who will keep us updated on the fundraising total.
The Maudsland Market in QLD chose MIA as the beneficiary of its monthly charity raffle in January. Along with the usual range of fresh produce, plants and other goodies, they raised $270 for MIA and raise awareness about melanoma. Thank you to Adrienne English and all who participated!
Another of our wonderful community fundraisers you may have seen highlighted on #fundraiserfriday is Renee Marchment. She completed her 6to6 swim at Crescent Aquatic Centre in Crescent Head. Renee took on the challenge to swim from 6 pm to 6 am to help raise awareness about melanoma as well as funds for MIA. Not only did Renee raise over $16,500 for melanoma research, but she was named ‘Citizen of the Year’ in the 2020 Crescent Head Australia Day Awards! Thank you and well done, Renee.
Also on the food theme, Fullerton Health in Cardiff hosted a two-day bake sale to celebrate Australia Day and raise funds for MIA. We thank everyone there, and all our devoted community fundraisers, for their continued support.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.